Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The treatment reduced coronavirus levels and sped up recovery in a clinical trial.
The new antigen test the White House is using has not been independently evaluated for accuracy and reliability.
Critics believe the order has no “technical content,” and that Trump wants his departments to come up with plan despite no clear guidance.
Plasma from recovered patients recently received a controversial FDA emergency use authorization as a potential treatment for COVID-19.
A coalition of LGBT groups sues the Trump administration over the rule. The lawsuit is “Whitman-Walker Clinic v. HHS.”
Should you worry about your supply? Plus: Vice President Pence and AIDS expert Deborah Birx lead the U.S. coronavirus response.
But it comes with deep cuts to Medicare, Medicaid, Social Security, cancer funds and other health and science programs.
Fact-checkers and HIV advocates break down the president’s State of the Union boasts.
The Trump administration’s efforts to ban service members who have HIV are not based on current science, the judge stated.
The American Cancer Society sets the record straight.
Opioid use disorder is fueling a rise in youth hepatitis C cases and a stabilization of a long decline in HIV among people who use drugs.
Acting Commissioner Ned Sharpless will return to lead the National Cancer Institute.
And yet, you have until December 15 to enroll in Obamacare for coverage beginning January 1.
Last year, the federal agency invested nearly $300 million in the search for HIV cure therapies.
How true is his statement? These facts add context.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.